ID   DIDH_RAT                Reviewed;         322 AA.
AC   P23457; Q5BKC8; Q6LDE6; Q6LDE7;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   24-JUL-2024, entry version 181.
DE   RecName: Full=3-alpha-hydroxysteroid dehydrogenase;
DE            Short=3-alpha-HSD;
DE            EC=1.1.1.50;
DE   AltName: Full=Hydroxyprostaglandin dehydrogenase;
GN   Name=Akr1c9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=1840601; DOI=10.1016/s0021-9258(18)31521-7;
RA   Pawlowski J.E., Huizinga M., Penning T.M.;
RT   "Cloning and sequencing of the cDNA for rat liver 3 alpha-
RT   hydroxysteroid/dihydrodiol dehydrogenase.";
RL   J. Biol. Chem. 266:8820-8825(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=1714456; DOI=10.1016/s0021-9258(18)98610-2;
RA   Stolz A., Rahimi-Kiani M., Ameis D., Chan E., Ronk M., Shively J.E.;
RT   "Molecular structure of rat hepatic 3 alpha-hydroxysteroid dehydrogenase. A
RT   member of the oxidoreductase gene family.";
RL   J. Biol. Chem. 266:15253-15257(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1922097; DOI=10.1210/mend-5-6-823;
RA   Cheng K.-C., White P.C., Qin K.-N.;
RT   "Molecular cloning and expression of rat liver 3 alpha-hydroxysteroid
RT   dehydrogenase.";
RL   Mol. Endocrinol. 5:823-828(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7515872; DOI=10.1093/oxfordjournals.jbchem.a124323;
RA   Usui E., Okuda K., Kato Y., Noshiro M.;
RT   "Rat hepatic 3 alpha-hydroxysteroid dehydrogenase: expression of cDNA and
RT   physiological function in bile acid biosynthetic pathway.";
RL   J. Biochem. 115:230-237(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10619355; DOI=10.1016/s0960-0760(99)00122-3;
RA   Lin H.K., Hung C.F., Moore M., Penning T.M.;
RT   "Genomic structure of rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase
RT   (3alpha-HSD/DD, AKR1C9).";
RL   J. Steroid Biochem. Mol. Biol. 71:29-39(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-16; 121-135; 152-166 AND 203-217.
RC   TISSUE=Liver;
RX   PubMed=7998972; DOI=10.1042/bj3040385;
RA   Del Bello B., Maellaro E., Sugherini L., Santucci A., Comporti M.,
RA   Casini A.F.;
RT   "Purification of NADPH-dependent dehydroascorbate reductase from rat liver
RT   and its identification with 3 alpha-hydroxysteroid dehydrogenase.";
RL   Biochem. J. 304:385-390(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 112-169 AND 238-322.
RX   PubMed=1793046; DOI=10.1007/bf01993305;
RA   Pawlowski J., Huizinga M., Penning T.M.;
RT   "Isolation and partial characterization of a full-length cDNA clone for 3
RT   alpha-hydroxysteroid dehydrogenase: a potential target enzyme for
RT   nonsteroidal anti-inflammatory drugs.";
RL   Agents Actions 34:289-293(1991).
RN   [9]
RP   PROTEIN SEQUENCE OF 162-171; 208-223 AND 232-246.
RX   PubMed=2026597; DOI=10.1016/s0021-9258(18)31522-9;
RA   Penning T.M., Abrams W.R., Pawlowski J.E.;
RT   "Affinity labeling of 3 alpha-hydroxysteroid dehydrogenase with 3 alpha-
RT   bromoacetoxyandrosterone and 11 alpha-bromoacetoxyprogesterone. Isolation
RT   and sequence of active site peptides containing reactive cysteines;
RT   sequence confirmation using nucleotide sequence from a cDNA clone.";
RL   J. Biol. Chem. 266:8826-8834(1991).
RN   [10]
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7626489; DOI=10.1016/0960-0760(95)00019-v;
RA   Khanna M., Qin K.-N., Cheng K.-C.;
RT   "Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and
RT   molecular cloning of multiple cDNAs encoding structurally related proteins
RT   in humans.";
RL   J. Steroid Biochem. Mol. Biol. 53:41-46(1995).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RC   TISSUE=Liver;
RX   PubMed=8146147; DOI=10.1073/pnas.91.7.2517;
RA   Hoog S.S., Pawlowski J.E., Alzari P.M., Penning T.M., Lewis M.;
RT   "Three-dimensional structure of rat liver 3 alpha-
RT   hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto
RT   reductase superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2517-2521(1994).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=8718859; DOI=10.1021/bi9604688;
RA   Bennett M.J., Schlegel B.P., Jez J.M., Penning T.M., Lewis M.;
RT   "Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed
RT   with NADP+.";
RL   Biochemistry 35:10702-10711(1996).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   TESTOSTERONE.
RX   PubMed=9261071; DOI=10.1016/s0969-2126(97)00234-7;
RA   Bennett M.J., Albert R.H., Jez J.M., Ma H., Penning T.M., Lewis M.;
RT   "Steroid recognition and regulation of hormone action: crystal structure of
RT   testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol
RT   dehydrogenase.";
RL   Structure 5:799-812(1997).
CC   -!- FUNCTION: Besides being a 3-alpha-hydroxysteroid dehydrogenase, the
CC       enzyme can accomplish diverse functions: as quinone reductase, as an
CC       aromatic alcohol dehydrogenase, as dihydrodiol dehydrogenase, and as
CC       9-, 11-, and 15-hydroxyprostaglandin dehydrogenase.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3alpha-hydroxysteroid + NADP(+) = a 3-oxosteroid + H(+) +
CC         NADPH; Xref=Rhea:RHEA:34783, ChEBI:CHEBI:15378, ChEBI:CHEBI:36835,
CC         ChEBI:CHEBI:47788, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.50;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3alpha-hydroxysteroid + NAD(+) = a 3-oxosteroid + H(+) +
CC         NADH; Xref=Rhea:RHEA:34779, ChEBI:CHEBI:15378, ChEBI:CHEBI:36835,
CC         ChEBI:CHEBI:47788, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.50;
CC   -!- ACTIVITY REGULATION: Potently inhibited by the nonsteroidal anti-
CC       inflammatory drugs (NSAID).
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9261071}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: In brain, highest levels found in olfactory bulb.
CC       Moderate levels present in cerebellum, cerebral cortex, hypothalamus
CC       and pituitary. Low levels present in amygdala, brain stem, caudate
CC       putamen, cingulate cortex, hippocampus, midbrain, and thalamus.
CC       {ECO:0000269|PubMed:7626489}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M64393; AAA40605.1; -; mRNA.
DR   EMBL; M61937; AAA41077.1; -; mRNA.
DR   EMBL; D17310; BAA04132.1; -; mRNA.
DR   EMBL; S57790; AAB19918.1; -; mRNA.
DR   EMBL; AF180334; AAF25813.1; -; Genomic_DNA.
DR   EMBL; AF180326; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180327; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180328; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180329; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180330; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180331; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180332; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; AF180333; AAF25813.1; JOINED; Genomic_DNA.
DR   EMBL; BC091123; AAH91123.1; -; mRNA.
DR   EMBL; S35751; AAB21512.1; -; mRNA.
DR   EMBL; S35752; AAB21513.1; -; mRNA.
DR   PIR; A39350; A39350.
DR   PIR; PC2175; PC2175.
DR   RefSeq; NP_612556.1; NM_138547.3.
DR   PDB; 1AFS; X-ray; 2.50 A; A/B=1-322.
DR   PDB; 1LWI; X-ray; 2.70 A; A/B=1-322.
DR   PDB; 1RAL; X-ray; 3.00 A; A=1-308.
DR   PDBsum; 1AFS; -.
DR   PDBsum; 1LWI; -.
DR   PDBsum; 1RAL; -.
DR   AlphaFoldDB; P23457; -.
DR   SMR; P23457; -.
DR   STRING; 10116.ENSRNOP00000023835; -.
DR   ChEMBL; CHEMBL1075221; -.
DR   iPTMnet; P23457; -.
DR   PhosphoSitePlus; P23457; -.
DR   jPOST; P23457; -.
DR   PaxDb; 10116-ENSRNOP00000023835; -.
DR   Ensembl; ENSRNOT00000023835.7; ENSRNOP00000023835.4; ENSRNOG00000017672.8.
DR   Ensembl; ENSRNOT00055030788; ENSRNOP00055024777; ENSRNOG00055018172.
DR   Ensembl; ENSRNOT00060026226; ENSRNOP00060020991; ENSRNOG00060015292.
DR   Ensembl; ENSRNOT00065005116; ENSRNOP00065003654; ENSRNOG00065003556.
DR   GeneID; 191574; -.
DR   KEGG; rno:191574; -.
DR   UCSC; RGD:708361; rat.
DR   AGR; RGD:708361; -.
DR   CTD; 105387; -.
DR   RGD; 708361; LOC191574.
DR   eggNOG; KOG1577; Eukaryota.
DR   GeneTree; ENSGT00940000153677; -.
DR   HOGENOM; CLU_023205_0_0_1; -.
DR   InParanoid; P23457; -.
DR   OMA; RSEYFVT; -.
DR   OrthoDB; 890110at2759; -.
DR   PhylomeDB; P23457; -.
DR   TreeFam; TF106492; -.
DR   BioCyc; MetaCyc:MONOMER-14305; -.
DR   BRENDA; 1.1.1.213; 5301.
DR   BRENDA; 1.1.1.50; 5301.
DR   BRENDA; 1.6.5.10; 5301.
DR   SABIO-RK; P23457; -.
DR   EvolutionaryTrace; P23457; -.
DR   PRO; PR:P23457; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000017672; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0047042; F:androsterone dehydrogenase (B-specific) activity; IEA:UniProtKB-EC.
DR   GO; GO:0047023; F:androsterone dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0032052; F:bile acid binding; IBA:GO_Central.
DR   GO; GO:0047086; F:ketosteroid monooxygenase activity; IBA:GO_Central.
DR   GO; GO:0016229; F:steroid dehydrogenase activity; IDA:RGD.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IBA:GO_Central.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IBA:GO_Central.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0042448; P:progesterone metabolic process; IBA:GO_Central.
DR   GO; GO:0006693; P:prostaglandin metabolic process; IBA:GO_Central.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:RGD.
DR   CDD; cd19108; AKR_AKR1C1-35; 1.
DR   DisProt; DP02646; -.
DR   Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1.
DR   InterPro; IPR020471; AKR.
DR   InterPro; IPR044482; AKR1C.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   PANTHER; PTHR11732:SF205; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 1.
DR   PANTHER; PTHR11732; ALDO/KETO REDUCTASE; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; NAD; NADP;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..322
FT                   /note="3-alpha-hydroxysteroid dehydrogenase"
FT                   /id="PRO_0000124654"
FT   ACT_SITE        55
FT                   /note="Proton donor"
FT   BINDING         20..24
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   BINDING         50
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   BINDING         117
FT                   /ligand="substrate"
FT   BINDING         166..167
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   BINDING         190
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   BINDING         216..221
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   BINDING         227
FT                   /ligand="substrate"
FT   BINDING         270..280
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:9261071"
FT   SITE            84
FT                   /note="Lowers pKa of active site Tyr"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="Blocked amino end (Met)"
FT   CONFLICT        108
FT                   /note="L -> Q (in Ref. 3; AAB19918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273..274
FT                   /note="NA -> KP (in Ref. 3; AAB19918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        280
FT                   /note="L -> P (in Ref. 3; AAB19918)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..5
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          7..9
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   TURN            11..13
FT                   /evidence="ECO:0007829|PDB:1RAL"
FT   STRAND          15..22
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   TURN            28..30
FT                   /evidence="ECO:0007829|PDB:1RAL"
FT   HELIX           33..43
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           58..70
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           76..78
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          80..85
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           95..106
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          109..117
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          124..129
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          131..137
FT                   /evidence="ECO:0007829|PDB:1RAL"
FT   HELIX           144..156
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          159..167
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           170..177
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          187..192
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           200..209
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   TURN            225..227
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           239..247
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           252..262
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   STRAND          266..269
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           274..280
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   TURN            281..284
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           290..297
FT                   /evidence="ECO:0007829|PDB:1AFS"
FT   HELIX           309..311
FT                   /evidence="ECO:0007829|PDB:1AFS"
SQ   SEQUENCE   322 AA;  37028 MW;  592EFC584726A4F6 CRC64;
     MDSISLRVAL NDGNFIPVLG FGTTVPEKVA KDEVIKATKI AIDNGFRHFD SAYLYEVEEE
     VGQAIRSKIE DGTVKREDIF YTSKLWSTFH RPELVRTCLE KTLKSTQLDY VDLYIIHFPM
     ALQPGDIFFP RDEHGKLLFE TVDICDTWEA MEKCKDAGLA KSIGVSNFNC RQLERILNKP
     GLKYKPVCNQ VECHLYLNQS KMLDYCKSKD IILVSYCTLG SSRDKTWVDQ KSPVLLDDPV
     LCAIAKKYKQ TPALVALRYQ LQRGVVPLIR SFNAKRIKEL TQVFEFQLAS EDMKALDGLN
     RNFRYNNAKY FDDHPNHPFT DE
//
